The Gist Healthcare Podcast

The Trump Administration reaches a deal to lower prices on weight loss drugs, the FDA fast-tracks biosimilars, and a new report shows UnitedHealthcare pays its Optum physicians more than others. Hear the latest on The Gist Healthcare Podcast.

On today’s episode of The Gist Healthcare Podcast, CMS finalizes a Medicare pay bump for physicians. Kimberly-Clark to purchase Tylenol maker Kenvue, and Pfizer sues to block Novo Nordisk’s merger with an obesity startup.

Millions of Americans relying on food assistance could lose benefits as the government shutdown continues. A new study explores how proposed H-1B visa changes may affect staffing in rural hospitals. Plus, a court ruling dismisses a case from nurse practitioners challenging the definition of “doctor.” All that and more on today’s episode of The Gist Healthcare Podcast.

Texas files suit against the maker of Tylenol, alleging hidden autism risks. Furloughed CMS employees are called back to manage Medicare and ACA enrollment. And Cigna takes a new approach to drug pricing by moving away from rebates. Hear these stories and more on The Gist Healthcare Podcast.

In this episode of the Gist Healthcare Podcast, the nation’s second-largest measles outbreak continues to expand along the Arizona–Utah border. Family job-based health insurance premiums hit an average of $27,000 in 2025, while UnitedHealth Group launches an AI tool designed to accelerate medical claims processing.

Moderate House Republicans are urging Speaker Mike Johnson to take up the issue of expiring Affordable Care Act tax credits once the shutdown ends. A new poll shows declining trust in President Trump and Health Secretary Robert F. Kennedy Jr., while DocGo moves to acquire SteadyMD. Those stories and more on The Gist Healthcare Podcast.

In today’s episode of The Gist Healthcare Podcast, we look at three headlines shaping healthcare this week: rising 2026 ACA exchange prices, California’s plan to sell its own insulin, and Prospect Medical Holdings’ move to sell more hospitals.

For decades, pregnant women have been excluded from most clinical drug trials. The policy was meant to protect mothers and babies, but it has left major gaps in medical knowledge. Now, renewed debate over the safety of common medicines like Tylenol has brought those gaps into sharp focus.   In this episode, STAT News reporter Lizzy Lawrence joins host J. Carlisle Larsen to discuss how history, politics, and caution shaped the science of pregnancy, and what it will take to ensure women are fully included in research that affects their health.  You can read her piece here.  

In today’s episode of The Gist Healthcare Podcast, we look at headlines making waves in the industry: Qualtrics’ plan to acquire Press Ganey Forsta in a multibillion-dollar deal, new polling that shows a decline in public trust in the CDC, and a report revealing that some potentially unnecessary back surgeries have cost Medicare nearly $2 billion over three years.